美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AgomAb Therapeutics

14.65

-1.3500-8.44%

盤後：15.100.4474+3.05%16:57 EST

成交量：236.18萬

成交額：3,364.10萬

市值：7.14億

市盈率：- -

高：15.49

開：14.70

低：12.66

收：16.00

52周最高：15.49

52周最低：12.66

股本：4,873.68萬

流通股本：1,250.00萬

量比：- -

換手率：18.89%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：-3.96

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

異動解讀 | 新股上市遇冷，AgomAb Therapeutics盤中大跌18.72%

比利時 Agomab Therapeutics 納斯達克首秀股價下跌，估值 7.16 億美元

比利時抗纖維化生物技術公司AgomAb Therapeutics(AGMB.US)啓動美股IPO 擬募資2億美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/AGMB"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AGMB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","market":"US","secType":"STK","nameCN":"AgomAb Therapeutics","latestPrice":14.65,"timestamp":1770411600000,"preClose":16,"halted":0,"volume":2361844,"hourTrading":{"tag":"盘后","latestPrice":15.0974,"preClose":14.65,"latestTime":"16:57 EST","volume":45580,"amount":660736.75042,"timestamp":1770415069163,"change":0.4474,"changeRate":0.030539,"amplitude":0.149768},"delay":0,"changeRate":-0.08437499999999998,"floatShares":12500000,"shares":48736779,"eps":0,"marketStatus":"盤後交易","change":-1.35,"latestTime":"02-06 17:05:04 EST","open":14.7,"high":15.49,"low":12.66,"amount":33640953.356128,"amplitude":0.176875,"askPrice":15.69,"askSize":100,"bidPrice":14.93,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1770426000000},"marketStatusCode":4,"adr":0,"listingDate":1770354000000,"exchange":"NASDAQ","adjPreClose":16,"postHourTrading":{"tag":"盘后","latestPrice":15.0974,"preClose":14.65,"latestTime":"16:57 EST","volume":45580,"amount":660736.75042,"timestamp":1770415069163,"change":0.4474,"changeRate":0.030539,"amplitude":0.149768},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","floatShares":12500000,"roa":"--","roe":"--","lyrEps":0,"shares":48736779,"dividePrice":0,"high":15.49,"amplitude":0.176875,"preClose":16,"low":12.66,"week52Low":12.66,"pbRate":"-3.96","week52High":15.49,"institutionHeld":0,"latestPrice":14.65,"eps":0,"divideRate":0,"volume":2361844,"delay":0,"ttmEps":0,"open":14.7,"prevYearClose":16,"fiveDayClose":16,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGMB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGMB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGMB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGMB\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1129897501","title":"異動解讀 | 新股上市遇冷，AgomAb Therapeutics盤中大跌18.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129897501","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129897501?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 01:54","pubTimestamp":1770400445,"startTime":"0","endTime":"0","summary":"AgomAb Therapeutics(AGMB)今日盘中股价大跌18.72%，引起了市场的广泛关注。消息面上，该公司于周五正式登陆美股市场，但新股表现不佳，开盘即大幅下跌。根据相关报道，其IPO价格为16美元，上市后股价持续走低，市场对其首秀反应冷淡。AgomAb Therapeutics是一家总部位于比利时的临床阶段生物制药公司，专注于开发针对免疫与炎症疾病的创新疗法。公司估值约为7.164亿美元，其核心候选药物针对纤维狭窄型克罗恩病等慢性纤维化适应症。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AGMB"],"gpt_icon":0},{"id":"2609513671","title":"比利時 Agomab Therapeutics 納斯達克首秀股價下跌，估值 7.16 億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609513671","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609513671?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 01:42","pubTimestamp":1770399754,"startTime":"0","endTime":"0","summary":"比利时 Agomab Therapeutics 纳斯达克首秀股价下跌，估值 7.16 亿美元路透2月6日 - Agomab Therapeutics AGMB.O周五在纳斯达克首次上市时股价下跌约8%，这家总部位于比利时的公司估值为7.164亿美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL4T3Z21UV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGMB"],"gpt_icon":0},{"id":"2607091502","title":"比利時抗纖維化生物技術公司AgomAb Therapeutics(AGMB.US)啓動美股IPO 擬募資2億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607091502","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607091502?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 15:16","pubTimestamp":1769757418,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，比利时二期生物科技公司AgomAb Therapeutics于美东时间周四公布了其美股IPO条款。该公司专注于开发针对克罗恩病及其他纤维化疾病的TGFβ抑制剂。按拟议发行价区间中值计算，AgomAb Therapeutics的完全稀释后市值将达到8.75亿美元。AgomAb Therapeutics是一家临床阶段生物制药公司，致力于开发针对免疫与炎症疾病的创新疾病修正疗法。AgomAb Therapeutics成立于2017年，计划以股票代码“AGMB”在纳斯达克上市。公司预计将于今年2月完成IPO定价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4539","LENZ","BK4588","AGMB","BK4585","VT","BK4007"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AGMB\",params:#limit:6,delay:false,,,undefined,":[]}}